In PAAD, PRAD, and LGG, YAP1 expression was positively correlated with the expression of CTLA-4, TIM-3 (HAVCR2), and PD-1 (PDCD1), which are key checkpoint regulators that suppress immune reaction. Here, PDCD1 is linked to pancreatic adenocarcinoma.